206 related articles for article (PubMed ID: 34165552)
21. Reduction of Tet2 exacerbates early stage Alzheimer's pathology and cognitive impairments in 2×Tg-AD mice.
Li L; Qiu Y; Miao M; Liu Z; Li W; Zhu Y; Wang Q
Hum Mol Genet; 2020 Jul; 29(11):1833-1852. PubMed ID: 31943063
[TBL] [Abstract][Full Text] [Related]
22. Tet family of 5-methylcytosine dioxygenases in mammalian development.
Zhao H; Chen T
J Hum Genet; 2013 Jul; 58(7):421-7. PubMed ID: 23719188
[TBL] [Abstract][Full Text] [Related]
23. Tet methylcytosine dioxygenase 2 inhibits atherosclerosis via upregulation of autophagy in ApoE-/- mice.
Peng J; Yang Q; Li AF; Li RQ; Wang Z; Liu LS; Ren Z; Zheng XL; Tang XQ; Li GH; Tang ZH; Jiang ZS; Wei DH
Oncotarget; 2016 Nov; 7(47):76423-76436. PubMed ID: 27821816
[TBL] [Abstract][Full Text] [Related]
24. TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions.
Broome R; Chernukhin I; Jamieson S; Kishore K; Papachristou EK; Mao SQ; Tejedo CG; Mahtey A; Theodorou V; Groen AJ; D'Santos C; Balasubramanian S; Farcas AM; Siersbæk R; Carroll JS
Cell Rep; 2021 Feb; 34(8):108776. PubMed ID: 33626359
[TBL] [Abstract][Full Text] [Related]
25. Ascorbic acid improves parthenogenetic embryo development through TET proteins in mice.
Gao W; Yu X; Hao J; Wang L; Qi M; Han L; Lin C; Wang D
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30567727
[TBL] [Abstract][Full Text] [Related]
26. Comparative dynamics of 5-methylcytosine reprogramming and TET family expression during preimplantation mammalian development in mouse and sheep.
Jafarpour F; Hosseini SM; Ostadhosseini S; Abbasi H; Dalman A; Nasr-Esfahani MH
Theriogenology; 2017 Feb; 89():86-96. PubMed ID: 28043375
[TBL] [Abstract][Full Text] [Related]
27. Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion.
Zhang Z; Jin Y; Zhang W; Chu C; Zhang K; Gao X; Zhou J; Zou L; Tang F; Wang H; Zou Q
J Clin Lab Anal; 2020 May; 34(5):e23162. PubMed ID: 31867779
[TBL] [Abstract][Full Text] [Related]
28. The TET2 interactors and their links to hematological malignancies.
Pan F; Weeks O; Yang FC; Xu M
IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
[TBL] [Abstract][Full Text] [Related]
29. 5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function.
Stoyanova E; Riad M; Rao A; Heintz N
Elife; 2021 Dec; 10():. PubMed ID: 34919053
[TBL] [Abstract][Full Text] [Related]
30. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
Eyres M; Lanfredini S; Xu H; Burns A; Blake A; Willenbrock F; Goldin R; Hughes D; Hughes S; Thapa A; Vavoulis D; Hubert A; D'Costa Z; Sabbagh A; Abraham AG; Blancher C; Jones S; Verrill C; Silva M; Soonawalla Z; Maughan T; Schuh A; Mukherjee S; O'Neill E
Gastroenterology; 2021 Aug; 161(2):653-668.e16. PubMed ID: 33915173
[TBL] [Abstract][Full Text] [Related]
31. TET2 Regulates Mast Cell Differentiation and Proliferation through Catalytic and Non-catalytic Activities.
Montagner S; Leoni C; Emming S; Della Chiara G; Balestrieri C; Barozzi I; Piccolo V; Togher S; Ko M; Rao A; Natoli G; Monticelli S
Cell Rep; 2016 May; 15(7):1566-1579. PubMed ID: 27160912
[TBL] [Abstract][Full Text] [Related]
32. Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells.
Huang Y; Chavez L; Chang X; Wang X; Pastor WA; Kang J; Zepeda-Martínez JA; Pape UJ; Jacobsen SE; Peters B; Rao A
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1361-6. PubMed ID: 24474761
[TBL] [Abstract][Full Text] [Related]
33. Engineered Split-TET2 Enzyme for Inducible Epigenetic Remodeling.
Lee M; Li J; Liang Y; Ma G; Zhang J; He L; Liu Y; Li Q; Li M; Sun D; Zhou Y; Huang Y
J Am Chem Soc; 2017 Apr; 139(13):4659-4662. PubMed ID: 28294608
[TBL] [Abstract][Full Text] [Related]
34. TET Enzymes and 5hmC in Adaptive and Innate Immune Systems.
Lio CJ; Rao A
Front Immunol; 2019; 10():210. PubMed ID: 30809228
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies.
Li W; Xu L
Oncol Res Treat; 2019; 42(6):309-318. PubMed ID: 31055566
[TBL] [Abstract][Full Text] [Related]
36. The expression of TET3 regulated cell proliferation in HepG2 cells.
Zhong X; Liu D; Hao Y; Li C; Hao J; Lin C; Shi S; Wang D
Gene; 2019 May; 698():113-119. PubMed ID: 30836118
[TBL] [Abstract][Full Text] [Related]
37. IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC.
Xu Q; Wang K; Wang L; Zhu Y; Zhou G; Xie D; Yang Q
PLoS One; 2016; 11(8):e0161261. PubMed ID: 27548812
[TBL] [Abstract][Full Text] [Related]
38. TET3 Mediates Alterations in the Epigenetic Marker 5hmC and Akt pathway in Steroid-Associated Osteonecrosis.
Zhao J; Ma XL; Ma JX; Sun L; Lu B; Wang Y; Xing GS; Wang Y; Dong BC; Xu LY; Kuang MJ; Fu L; Bai HH; Ma Y; Jin WL
J Bone Miner Res; 2017 Feb; 32(2):319-332. PubMed ID: 27627619
[TBL] [Abstract][Full Text] [Related]
39. Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications.
Lopez-Bertoni H; Johnson A; Rui Y; Lal B; Sall S; Malloy M; Coulter JB; Lugo-Fagundo M; Shudir S; Khela H; Caputo C; Green JJ; Laterra J
Signal Transduct Target Ther; 2022 Feb; 7(1):37. PubMed ID: 35136034
[TBL] [Abstract][Full Text] [Related]
40. Structural insight into substrate preference for TET-mediated oxidation.
Hu L; Lu J; Cheng J; Rao Q; Li Z; Hou H; Lou Z; Zhang L; Li W; Gong W; Liu M; Sun C; Yin X; Li J; Tan X; Wang P; Wang Y; Fang D; Cui Q; Yang P; He C; Jiang H; Luo C; Xu Y
Nature; 2015 Nov; 527(7576):118-22. PubMed ID: 26524525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
